The pathophysiological responses that occur after a stroke are complicated, and at present, tissue plasminogen activator remains the most efficacious treatment option for stroke [12,13], effective only when taken within 4–6 h of the onset of symptoms [14,15]. The gene discussed is PLAT; the disease is stroke disorder.